CliffBio
small molecule

NIASPAN TITRATION STARTER PACK

NIACIN

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameNIASPAN TITRATION STARTER PACK
Active ingredientNIACIN
Strength375MG;500MG;750MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 1997
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NIASPAN TITRATION STARTER PACK patent cliff — loss of exclusivity — | CliffBio